Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of CSCJC3456 in Patients With Advanced Malignant Tumors — Stella

Home/Advanced Malignant Solid Tumors/A Study of CSCJC3456 in Patients With Advanced Malignant Tumors

View on ClinicalTrials.gov

Recruiting

Back to Advanced Malignant Solid Tumors trials

A Study of CSCJC3456 in Patients With Advanced Malignant Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

China

Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

The First Hospital of China Medical University, Shenyang, Liaoning

Key details

Phase

Early testing

Sponsor

Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.

Enrollment target

~102 participants

Started

February 2025

Primary completion

June 2027

Age range

18 Years – 75 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.